瑪嘉烈醫院是香港醫院管理局轄下的一所大型公立綜合醫院，位於新界葵青區下葵涌茘枝角灣瑪嘉烈醫院道2-10號。醫院成立於1975年，現有超過1,700張病床及4,000多名員工。 瑪嘉烈醫院毗鄰葵涌醫院，由醫院管理局管理，屬於九龍西聯網，主要為荔枝角、新界西南以至東涌和大嶼山的居民提供服務。

During the past decade, Princess Margaret Hospital conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 25 clinical trials were completed, i.e. on average, 46.3% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 17 clinical trials were completed. i.e. 56.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Princess Margaret Hospital" #1 sponsor was "Gilead Sciences" with 14 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Hospital Authority, Hong Kong" with 9 trials sponsored, "Chinese University of Hong Kong" with 7 trials sponsored and "The University of Hong Kong" with 7 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Princess Margaret Hospital" #1 collaborator was "Gilead Sciences" with 5 trials as a collaborator, "Princess Margaret Hospital, Hong Kong" with 5 trials as a collaborator, "Kwong Wah Hospital" with 4 trials as a collaborator, "Pamela Youde Nethersole Eastern Hospital" with 4 trials as a collaborator and "Queen Elizabeth Hospital, Hong Kong" with 4 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Princess Margaret Hospital" are "Breast Cancer" (4 trials), "COVID-19" (4 trials), "Chronic Hepatitis B" (3 trials), "Colorectal Cancer" (3 trials) and "Influenza" (3 trials). Many other conditions were trialed in "Princess Margaret Hospital" in a lesser frequency.

Most popular intervention types in "Princess Margaret Hospital" are "Drug" (56 trials), "Other" (11 trials), "Device" (7 trials), "Biological" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Pembrolizumab" (5 trials), "Cisplatin" (4 trials), "Filgotinib" (4 trials) and "Magrolimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Princess Margaret Hospital" are 73 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Princess Margaret Hospital". undefined are not yet recruiting, 12 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 39 completed trials in Princess Margaret Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Princess Margaret Hospital, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 17 trials that are defined as “Not Applicable".

Princess Margaret Hospital has several departments that took part in Clinical trials: "Duchess of Kent Children's Hospital" - 17 trials